This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aqtis I.p. B.v.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Pieter Gerard Zijlstra: Innovator in Microparticle Technology
Introduction
Pieter Gerard Zijlstra is a notable inventor based in Hilversum, Netherlands. He has made significant contributions to the field of microparticle technology, holding 2 patents that focus on innovative applications of PCL-comprising microparticles.
Latest Patents
Zijlstra's latest patents revolve around the development of microparticles comprising PCL and their various uses. The invention details a process for preparing these microparticles, which can be utilized in creating a gel. This gel has multiple applications, including the preparation of medicaments for treating skin abnormalities, controlling bladder function, managing gastric reflux, treating erectile dysfunction, and addressing vocal cord issues. Additionally, the gel is suitable for cosmetic applications, showcasing its versatility in both medical and aesthetic fields.
Career Highlights
Pieter Gerard Zijlstra is associated with Aqtis I.P. B.V., where he continues to advance his research and development efforts. His work in microparticle technology has positioned him as a key figure in the industry, contributing to innovative solutions that address various health concerns.
Collaborations
Zijlstra collaborates with esteemed colleagues such as Paul Willem Mijnen and Dirk Wybe Grijpma. Their combined expertise enhances the research and development efforts at Aqtis I.P. B.V., fostering an environment of innovation.
Conclusion
Pieter Gerard Zijlstra's contributions to microparticle technology exemplify the impact of innovative thinking in addressing complex health issues. His patents and ongoing work continue to pave the way for advancements in both medical and cosmetic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile